Clinical Trial 23101

Disease Site: Other Hematopoietic

PI: Fernandez, Hugo

Clinical Trial 23303

Phase III Study of Local or Systemic Therapy INtensification DIrected by PET in Prostate CAncer Patients with Post-ProstaTEctomy Biochemical Recurrence (INDICATE)

Disease Site: Prostate

PI: Yamoah, Kosj

Clinical Trial 20571

Optimizing Cellular and Humoral Immunity to Pneumococcus by Vaccination with Pneumococcal 13-valent conjugate vaccine before and after CD19-targeted CAR T-cell Immunotherapy

Disease Site: Lymphoma, Non-Hodgkin's Lymphoma

PI: Locke, Frederick

Clinical Trial 20894

Acalabrutinib for Chronic Graft-versus-Host Disease

Disease Site: Unknown Sites

PI: Pidala, Joseph

Clinical Trial 21193

Disease Site: Brain and Nervous System, Brain metastasis

PI: Yu, Hsiang-Hsuan (Michael)

Clinical Trial 21027

A Phase 2 Multicenter Study of Autologous Tumor Infiltrating Lymphocytes (LN-145) in Patients with Metastatic Non-Small-Cell Lung Cancer

Disease Site: Lung, Non small cell lung cancer

PI: Creelan, Benjamin

Clinical Trial 19722

A Phase 2, Multi-Cohort, Open-Label, Multicenter Study To Determine The Efficacy And Safety Of Bb2121 In Subjects With Relapsed And Refractory Multiple Myeloma And In Subjects With High-Risk Multiple Myeloma Having Progressed Within One Year Of Initial Treatment

Disease Site: Multiple Myeloma

PI: Alsina, Melissa

Clinical Trial 21158

Disease Site: Lung

PI: Gray, Jhanelle

Clinical Trial 21247

A Randomized Open-Label, Phase 3 Study to Evaluate Imetelstat (GRN163L) Versus Best Available Therapy (BAT) in Patients with Intermediate-2 or High-risk Myelofibrosis (MF) Relapsed / Refractory (R/R) to Janus Kinase (JAK)-Inhibitor

Disease Site: Myeloid and Monocytic Leukemia

PI: Komrokji, Rami

Clinical Trial 20897

Phase 1 Dose-Escalation, Dose-Expansion Trial of Intratumoral HER2- and HER3-Primed Dendritic Cells Injections for the Treatment of Early-Stage TNBC and ER Low Positive Breast Cancer (DecipHER)

Disease Site: Breast

PI: Costa, Ricardo

Clinical Trial 20731

Phase 2 Study of Afatinib in Advanced Cutaneous Squamous Cell Carcinoma

Disease Site: Other Skin, Squamous Cell Carcinoma (SCC)

PI: Eroglu, Zeynep

Clinical Trial 21621

A Phase 3 Randomized, Open-Label, Multicenter Study Evaluating the Efficacy of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Subjects with Relapsed/Refractory Follicular Lymphoma

Disease Site: Non-Hodgkin's Lymphoma

PI: Gaballa, Sameh